Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36501 - 36525 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	ALPK1	80216	upregulated	entinostat results in increased expression of ALPK1 mRNA	4q25	A21037
Entinostat	Investigational	AMBP	259	upregulated	entinostat results in increased expression of AMBP mRNA	9q32	A21037
Entinostat	Investigational	AMER1	139285	downregulated	entinostat results in decreased expression of AMER1 mRNA	Xq11.2	A21035
Entinostat	Investigational	ANG	283	upregulated	entinostat results in increased expression of ANG mRNA	14q11.2	A21037
Entinostat	Investigational	ANGPTL4	51129	upregulated	entinostat results in increased expression of ANGPTL4 mRNA	19p13.2	A21035
Entinostat	Investigational	ANK2	287	upregulated	entinostat results in increased expression of ANK2 mRNA	4q25-q26	A21037
Entinostat	Investigational	ANK3	288	downregulated	entinostat results in decreased expression of ANK3 mRNA	10q21.2	A21035
Entinostat	Investigational	ANKDD1A	348094	upregulated	entinostat results in increased expression of ANKDD1A mRNA	15q22.31	A21035
Entinostat	Investigational	ANKEF1	63926	upregulated	entinostat results in increased expression of ANKEF1 mRNA	20p12.2	A21037
Entinostat	Investigational	ANKH	56172	upregulated	entinostat results in increased expression of ANKH mRNA	5p15.2	A21037
Entinostat	Investigational	ANKLE1	126549	upregulated	entinostat results in increased expression of ANKLE1 mRNA	19p13.11	A21037
Entinostat	Investigational	ANKRD10	55608	downregulated	entinostat results in decreased expression of ANKRD10 mRNA	13q34	A21035
Entinostat	Investigational	ANKRD18A	253650	upregulated	entinostat results in increased expression of ANKRD18A mRNA	9p13.1	A21035
Entinostat	Investigational	ANKRD28	23243	downregulated	entinostat results in decreased expression of ANKRD28 mRNA	3p25.1	A21037
Entinostat	Investigational	ANKRD33B	651746	upregulated	entinostat results in increased expression of ANKRD33B mRNA	5p15.2	A21035
Entinostat	Investigational	ANKRD35	148741	downregulated	entinostat results in decreased expression of ANKRD35 mRNA	1q21.1	A21035
Entinostat	Investigational	ANKRD37	353322	downregulated	entinostat results in decreased expression of ANKRD37 mRNA	4q35.1	A21037
Entinostat	Investigational	ANKRD44	91526	downregulated	entinostat results in decreased expression of ANKRD44 mRNA	2q33.1	A21037
Entinostat	Investigational	ANKRD55	79722	upregulated	entinostat results in increased expression of ANKRD55 mRNA	5q11.2	A21035
Entinostat	Investigational	ANKRD6	22881	upregulated	entinostat results in increased expression of ANKRD6 mRNA	6q15	A21035
Entinostat	Investigational	ANKS1B	56899	downregulated	entinostat results in decreased expression of ANKS1B mRNA	12q23.1	A21037
Entinostat	Investigational	ANO3	63982	upregulated	entinostat results in increased expression of ANO3 mRNA	11p14.2	A21037
Entinostat	Investigational	ANO4	121601	upregulated	entinostat results in increased expression of ANO4 mRNA	12q23.1	A21035
Entinostat	Investigational	ANTXR1	84168	upregulated	entinostat results in increased expression of ANTXR1 mRNA	2p13.3	A21037
Entinostat	Investigational	ANTXR2	118429	downregulated	entinostat results in decreased expression of ANTXR2 mRNA	4q21.21	A21037

Displaying entries 36501 - 36525 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability